Login / Signup

A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3-ITD mutational status.

Kebede H BegnaWalid AliNaseema GangatMichelle A ElliottAref Al-KaliMark R LitzowC Christopher HookAlexandra P WolanskyjWilliam J HoganMirinal S PatnaikAnimesh PardananiDarci L ZblewskiDong ChenRong HeDavid ViswanathaCurtis A HansonRhett P KetterlingAyalew Tefferi
Published in: American journal of hematology (2018)
Keyphrases
  • acute myeloid leukemia
  • tyrosine kinase
  • combination therapy
  • replacement therapy